Nozaki T, Rosenblum J M, Schenk A D, Ishii D, Fairchild R L
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Am J Transplant. 2009 Oct;9(10):2251-61. doi: 10.1111/j.1600-6143.2009.02786.x. Epub 2009 Jul 28.
The effector CD4 T-cell response in wild-type C57BL/6 recipients of single class II MHC-disparate B6.H-2(bm12) cardiac allografts is restricted by CD4(+)CD25(+) regulatory T cells (Tregs) resulting in long-term allograft survival. To investigate the role chemokine receptors might play in Treg function, this study tested the requirement for CCR5 on Tregs to suppress the alloimmune response in C57BL/6 recipients of B6.H-2(bm12) cardiac allografts. In contrast to the long-term survival of B6.H-2(bm12) allografts in wild-type recipients (>100 days), the allografts were acutely rejected within 25 days in CCR5(-/-) recipients with intense infiltration of CD4 T cells. Numbers and duration of donor-reactive CD4 T cells producing IFN-gamma and IL-4 were markedly increased in spleens of B6.CCR5(-/-) versus wild-type recipients. Wild-type and B6.CCR5(-/-) mice had equivalent numbers of splenic FoxP3(+) Tregs before and following transplantation, and these Tregs were equivalently suppressive in vitro. However, diminished numbers of FoxP3(+) Tregs infiltrated B6.H-2(bm12) allografts in B6.CCR5(-/-) recipients. Adoptive transfer of wild-type, but not CCR5-deficient, CD4(+)CD25(+) Tregs to CCR5(-/-) recipients restored long-term survival of B6.H-2(bm12) cardiac grafts. Collectively, these results indicate that CCR5 expression is required for the regulatory functions of Tregs that restrict alloreactive CD4 T-cell responses to single class II MHC-mismatched cardiac allografts.
在单一II类主要组织相容性复合体(MHC)不相合的B6.H-2(bm12)心脏同种异体移植的野生型C57BL/6受体中,效应性CD4 T细胞反应受到CD4(+)CD25(+)调节性T细胞(Tregs)的限制,从而导致同种异体移植长期存活。为了研究趋化因子受体在Treg功能中可能发挥的作用,本研究检测了Tregs上CCR5对于抑制B6.H-2(bm12)心脏同种异体移植的C57BL/6受体中的同种免疫反应的必要性。与野生型受体中B6.H-2(bm12)同种异体移植的长期存活(>100天)相反,CCR5基因敲除受体中的同种异体移植在25天内被急性排斥,伴有CD4 T细胞的强烈浸润。与野生型受体相比,B6.CCR5基因敲除受体脾脏中产生IFN-γ和IL-4的供体反应性CD4 T细胞的数量和持续时间显著增加。移植前后,野生型和B6.CCR5基因敲除小鼠脾脏中FoxP3(+) Treg数量相当,且这些Tregs在体外具有同等的抑制作用。然而,B6.CCR5基因敲除受体中浸润到B6.H-2(bm12)同种异体移植中的FoxP3(+) Treg数量减少。将野生型而非CCR5缺陷型的CD4(+)CD25(+) Tregs过继转移到CCR5基因敲除受体中,可恢复B6.H-2(bm12)心脏移植物的长期存活。总体而言,这些结果表明,CCR5表达对于限制对单一II类MHC不匹配心脏同种异体移植的同种反应性CD4 T细胞反应的Tregs的调节功能是必需的。